Concepts (49)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leiomyoma | 2 | 2021 | 18 | 1.390 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 674 | 0.870 |
Why?
|
| Bronchial Neoplasms | 1 | 2021 | 6 | 0.720 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2021 | 8 | 0.710 |
Why?
|
| Pulmonary Atelectasis | 1 | 2021 | 11 | 0.710 |
Why?
|
| Anemia, Sickle Cell | 1 | 2021 | 63 | 0.680 |
Why?
|
| Lymphoma | 1 | 2021 | 103 | 0.670 |
Why?
|
| Bronchoscopy | 1 | 2020 | 90 | 0.660 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2016 | 8 | 0.520 |
Why?
|
| Plasma Exchange | 1 | 2016 | 23 | 0.520 |
Why?
|
| Rituximab | 1 | 2016 | 87 | 0.500 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2016 | 164 | 0.460 |
Why?
|
| Disease Management | 1 | 2016 | 232 | 0.450 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 264 | 0.420 |
Why?
|
| Hepatopulmonary Syndrome | 1 | 2021 | 1 | 0.180 |
Why?
|
| Carboxyhemoglobin | 1 | 2021 | 12 | 0.180 |
Why?
|
| Tracheal Neoplasms | 1 | 2021 | 4 | 0.180 |
Why?
|
| Carbon Monoxide | 1 | 2021 | 62 | 0.180 |
Why?
|
| End Stage Liver Disease | 1 | 2021 | 33 | 0.180 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2020 | 15 | 0.170 |
Why?
|
| Fluoroscopy | 1 | 2020 | 65 | 0.170 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 173 | 0.160 |
Why?
|
| Lymph Nodes | 1 | 2020 | 226 | 0.160 |
Why?
|
| Liver Transplantation | 1 | 2021 | 216 | 0.150 |
Why?
|
| Parvovirus B19, Human | 1 | 2019 | 5 | 0.150 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2019 | 10 | 0.150 |
Why?
|
| Parvoviridae Infections | 1 | 2019 | 23 | 0.150 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2019 | 68 | 0.150 |
Why?
|
| Methylprednisolone | 1 | 2017 | 34 | 0.140 |
Why?
|
| Rhabdomyolysis | 1 | 2017 | 23 | 0.140 |
Why?
|
| Glucocorticoids | 1 | 2017 | 189 | 0.120 |
Why?
|
| Immunologic Factors | 1 | 2016 | 105 | 0.120 |
Why?
|
| Humans | 7 | 2021 | 63437 | 0.120 |
Why?
|
| Adult | 3 | 2020 | 16826 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 1644 | 0.100 |
Why?
|
| Male | 3 | 2021 | 29897 | 0.060 |
Why?
|
| Female | 3 | 2021 | 32875 | 0.050 |
Why?
|
| Etoposide | 1 | 2019 | 34 | 0.040 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2019 | 137 | 0.040 |
Why?
|
| Creatine Kinase | 1 | 2017 | 42 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2019 | 205 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 464 | 0.030 |
Why?
|
| Fluid Therapy | 1 | 2017 | 49 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2017 | 201 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 1552 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 860 | 0.030 |
Why?
|
| Young Adult | 1 | 2019 | 4692 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 14436 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 17602 | 0.010 |
Why?
|